AH-001 another topical AR degrader beside GT20029, completed Phase I
    Research/Science 11/13/2025

    At a glance
    In this educational post, the primary subjects mentioned are
    ๐Ÿ’ง AH-001 (topical)
    the tone is ๐Ÿ˜€ positive.

    Other terms

    AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the side effects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 768 results

      community Testosterone and hair loss seeming irrelevance

      in Research/Science  79 upvotes 2 years ago
      The conversation is about the role of testosterone in hair loss and the effectiveness of different treatments. The conclusion is that DHT is the main culprit for hair loss, and finasteride has been proven to work long-term in maintaining and regrowing hair. Testosterone may have a minor effect, but it is not the primary cause of hair loss.

      community Why isnt topical fin talked about more?

      in Chat  44 upvotes 1 year ago
      Topical finasteride is less popular due to inconvenience, cost, and availability, while oral finasteride is favored for ease and safety. Some users experience side effects with topical use, but find it effective with minoxidil, though opinions on its efficacy vary.

      community DHT and 5AR respect post, it's importance within the brain

      in Research/Science  111 upvotes 2 years ago
      The conversation discusses whether to use finasteride for hair loss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.

      community GT20029 Phase 2 results are out

      in Treatment  60 upvotes 3 months ago
      GT20029 shows promising results for hair loss treatment, with potential approval in China by 2026 or 2027, but U.S. approval may take longer. It could serve as an alternative to finasteride, with a potentially better side effect profile.

    Related Research

    6 / 1000+ results